The neurobiology and clinical significance of depersonalization in mood and anxiety disorders: A critical reappraisal

Journal of Affective Disorders

Volumn 99, Issue 1-3, 2007, Pages 91-99

  Mula, Marco ^a   Pini, Stefano ^a   Cassano, Giovanni B ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Amygdala; Bipolar disorder; Depersonalization; Derealization; Major depression; Panic disorder

Indexed keywords

AMYGDALOID NUCLEUS; ANXIETY DISORDER; ARTICLE; CINGULATE GYRUS; COMORBIDITY; DEPERSONALIZATION; DISEASE SEVERITY; EMOTIONAL DISORDER; HUMAN; LIMBIC SYSTEM; MOOD DISORDER; NERVE CELL NETWORK; NEUROBIOLOGY; PREFRONTAL CORTEX; PRIORITY JOURNAL; SYMPTOMATOLOGY; TEMPORAL LOBE;

AMYGDALA; ANXIETY DISORDERS; BIPOLAR DISORDER; BRAIN; CEREBRAL CORTEX; CHRONIC DISEASE; DEPERSONALIZATION; DEPRESSIVE DISORDER, MAJOR; DOMINANCE, CEREBRAL; HUMANS; LIMBIC SYSTEM; NERVE NET; PANIC DISORDER; PROGNOSIS; TEMPORAL LOBE;

EID: 33847157998     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2006.08.025     Document Type: Article

References (89)

1. Abbas S., Chandra P.S., and Srivastava M. The use of fluoxetine and buspirone for treatment-refractory depersonalization disorder. J. Clin. Psychiatry 56 (1995) 484
2. Ackner B. Depersonalization. I. Aetiology and phenomenology; II. Clinical syndromes. J. Ment. Sci. 100 I, II (1954) 838-872
3. Ackner B., Grant O.A., and Maxwell A.E. The prognostic significance of depersonalization in depressive illnesses treated with electroconvulsive therapy. J. Neurol. Neurosurg. Psychiatry 23 (1960) 242-246
4. Adolphs R., Tranel D., Damasio H., and Damasio A. Impaired recognition of emotion in facial expressions following bilateral damage to the human amygdala. Nature 372 (1994) 669-672
5. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. (1994), American Psychiatric Association, Washington, DC
6. Ball S., Robinson A., Shekhar A., and Walsh K. Dissociative symptoms in panic disorder. J. Nerv. Ment. Dis. 185 (1997) 755-760
7. Bebbington P.E., Hurry J., Tennant C., Sturt E., and Wing J.K. Epidemiology of mental disorders in Camberwell. Psychol. Med. 11 (1981) 561-579
8. Bebbington P.E., Marsden L., and Brewin C.R. The need for psychiatric treatment in the general population: the Camberwell needs for care survey. Psychol. Med. 27 (1997) 821-834
9. Benkelfat C., Mefford I.N., Masters C.F., Nordahl T.E., King A.C., Cohen R.M., and Murphy D.L. Plasma catecholamines and their metabolites in obsessive-compulsive disorder. Psychiatry Res. 37 (1991) 321-331
10. Bohus M.J., Landwehrmeyer G.B., Stiglmayr C.E., Limberger M.F., Bohme R., and Schmahl C.G. Naltrexone in the treatment of dissociative symptoms in patients with borderline personality disorder: an open-label trial. J. Clin. Psychiatry 60 (1999) 598-603
11. Bremner J.D. Brain imaging in anxiety disorders. Exp. Rev. Neurotherapeutics 4 (2004) 275-284
12. Bremner J.D., Steinberg M., Southwick S.M., Johnson D.R., and Charney D.S. Use of the Structured Clinical Interview for DSM-IV Dissociative Disorders for systematic assessment of dissociative symptoms in posttraumatic stress disorder. Am. J. Psychiatry 150 (1993) 1011-1014
13. Buchel C., Morris J., Dolan R.J., and Friston K.J. Brain systems mediating aversive conditioning: an event-related fMRI study. Neuron 20 (1998) 947-957
14. Cahill L., Haier R.J., Fallon J., Alkire M.T., Tang C., Keator D., Wu J., and McGaugh J.L. Amygdala activity at encoding correlated with long-term, free recall of emotional information. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 8016-8021
15. Cassano G.B., Petracca A., Perugi G., Toni C., Tundo A., and Roth M. Derealization and panic attacks: a clinical evaluation on 150 patients with panic disorder/agoraphobia. Compr. Psychiatry 30 (1989) 5-12
16. Critchley H.D., Mathias C.J., Josephs O., O'Doherty J., Zanini S., Dewar B.K., Cipolotti L., Shallice T., and Dolan R.J. Human cingulate cortex and autonomic control: converging neuroimaging and clinical evidence. Brain 126 (2003) 2139-2152
17. Davidson J.R., Kudler H.S., Saunders W.B., and Smith R.D. Symptom and comorbidity patterns in World War II and Vietnam veterans with posttraumatic stress disorder. Compr. Psychiatry 31 (1990) 162-170
18. Davidson R.J., and Sutton S.K. Affective neuroscience: the emergence of a discipline. Curr. Opin. Neurobiol. 5 (1995) 217-224
19. Di Michele V., and Bolino F. Adjunctive citalopram is effective on hallucinations and depersonalization symptoms: a case report. Eur. Psychiatry 19 (2004) 185
20. Downer J.L. Changes in visual gnostic functions and emotional behaviour following unilateral temporal pole damage in the 'split-brain' monkey. Nature 191 (1961) 50-51
21. Drevets W.C., Videen T.O., Price J.L., Preskorn S.H., Carmichael S.T., and Raichle M.E. A functional anatomical study of unipolar depression. J. Neurosci. 12 (1992) 3628-3641
22. Eriksson N.G., and Lundin T. Early traumatic stress reactions among Swedish survivors of the M/S Estonia disaster. Br. J. Psychiatry 169 (1996) 713-716
23. Fichtner C.G., Horevitz R.P., and Braun B.G. Fluoxetine in depersonalization disorder. Am. J. Psychiatry 149 (1992) 1750-1751
24. Frank E., Cyranowski J.M., Rucci P., Shear M.K., Fagiolini A., Thase M.E., Cassano G.B., Grochocinski V.J., Kostelnik B., and Kupfer D.J. Clinical significance of lifetime panic spectrum symptoms in the treatment of patients with bipolar I disorder. Arch. Gen. Psychiatry 59 (2002) 905-911
25. Freeman M.P., Freeman S.A., and McElroy S.L. The comorbidity of bipolar and anxiety disorders: prevalence, psychobiology, and treatment issues. J. Affect. Disord. 68 (2002) 1-23
26. Geschwind N. Disconnexion syndromes in animals and man: I. Brain 88 (1965) 237-294
27. Geschwind N. Disconnexion syndromes in animals and man: II. Brain 88 (1965) 585-644
28. Gill D., and Lambourn J. Indications for electric convulsion therapy and its use by senior psychiatrists. Br. Med. J. 6172 (1979) 1169-1171
29. Gloor P. Experiential phenomena of temporal lobe epilepsy. Facts and hypotheses. Brain 113 (1990) 1673-1694
30. Glover H. A preliminary trial of nalmefene for the treatment of emotional numbing in combat veterans with post-traumatic stress disorder. Isr. J. Psychiatry Relat. Sci. 30 (1993) 255-263
31. Goodwin F.K., and Jamison K.R. Manic Depressive Illness (1990), Oxford University Press, New York
32. Goodwin R.D., and Hoven C.W. Bipolar-panic comorbidity in the general population: prevalence and associated morbidity. J. Affect. Disord. 70 (2002) 27-33
33. Hamann S.B., Stefanacci L., Squire L.R., Adolphs R., Tranel D., Damasio H., and Damasio A. Recognizing facial emotion. Nature 379 (1996) 497
34. Hunter E.C., Sierra M., and David A.S. The epidemiology of depersonalisation and derealisation. A systematic review. Soc. Psychiatry Psychiatr. Epidemiol. 39 (2004) 9-18
35. Jimenez-Genchi A.M. Repetitive transcranial magnetic stimulation improves depersonalization: a case report. CNS Spectr. 9 (2004) 375-376
36. Katerndahl D.A. Predictors of the development of phobic avoidance. J. Clin. Psychiatry 61 (2000) 618-623
37. LeDoux J.E., Iwata J., Cicchetti P., and Reis D.J. Different projections of the central amygdaloid nucleus mediate autonomic and behavioral correlates of conditioned fear. J. Neurosci. 8 (1988) 2517-2529
38. Madden IV J., Akil H., Patrick R.L., and Barchas J.D. Stress-induced parallel changes in central opioid levels and pain responsiveness in the rat. Nature 265 (1977) 358-360
39. Marquez M., Segui J., Garcia L., Canet J., and Ortiz M. Is panic disorder with psychosensorial symptoms (depersonalization-derealization) a more severe clinical subtype?. J. Nerv. Ment. Dis. 189 (2001) 332-335
40. Mayer-Gross W. On depersonalization. Br. J. Med. Psychol. 15 (1935) 103-126
41. Michaels A.J., Michaels C.E., Moon C.H., Smith J.S., Zimmerman M.A., Taheri P.A., and Peterson C. Posttraumatic stress disorder after injury: impact on general health outcome and early risk assessment. J. Trauma 47 (1999) 460-466
42. Michal M., Kaufhold J., Grabhorn R., Krakow K., Overbeck G., and Heidenreich T. Depersonalization and social anxiety. J. Nerv. Ment. Dis. 193 (2005) 629-632
43. Mizobe Y., Yamada K., and Fujii I. The sequence of panic symptoms. Jpn. J. Psychiatry Neurol. 46 (1992) 597-601
44. Morris J.S., Friston K.J., and Dolan R.J. Neural responses to salient visual stimuli. Proc. R. Soc. Lond., B Biol. Sci. 264 (1997) 769-775
45. Noyes Jr. R., and Kletti R. Depersonalization in response to life-threatening danger. Compr. Psychiatry 18 (1977) 375-384
46. Noyes Jr. R., Kuperman S., and Olson S.B. Desipramine: a possible treatment for depersonalization disorder. Can. J. Psychiatry 32 (1987) 782-784
47. Noyes Jr. R., Woodman C., Garvey M.J., Cook B.L., Suelzer M., Clancy J., and Anderson D.J. Generalized anxiety disorder vs. panic disorder. Distinguishing characteristics and patterns of comorbidity. J. Nerv. Ment. Dis. 180 (1992) 369-379
48. Nuller Y.L. Depersonalisation - symptoms, meaning, therapy. Acta Psychiatr. Scand. 66 (1982) 451-458
49. Nuller Y.L., Morozova M.G., Kushnir O.N., and Hamper N. Effect of naloxone therapy on depersonalization: a pilot study. J. Psychopharmacol. 15 (2001) 93-95
50. Paus T., and Barrett J. Transcranial magnetic stimulation (TMS) of the human frontal cortex: implications for repetitive TMS treatment of depression. J. Psychiatry Neurosci. 29 (2004) 268-279
51. Persson G., and Nordlund C.L. Agoraphobics and social phobics: differences in background factors, syndrome profiles and therapeutic response. Acta Psychiatr. Scand. 71 (1985) 148-159
52. Perugi G., Toni C., and Akiskal H.S. Anxious-bipolar comorbidity. Diagnostic and treatment challenges. Psychiatr. Clin. North Am. 22 (1999) 565-583 (viii)
53. Phillips M.L., Medford N., Senior C., Bullmore E.T., Suckling J., Brammer M.J., Andrew C., Sierra M., Williams S.C., and David A.S. Depersonalization disorder: thinking without feeling. Psychiatry Res. 108 (2001) 145-160
54. Pini S., Cassano G.B., Simonini E., Savino M., Russo A., and Montgomery S.A. Prevalence of anxiety disorders comorbidity in bipolar depression, unipolar depression and dysthymia. J. Affect. Disord. 42 (1997) 145-153
55. Pitman R.K., van der Kolk B.A., Orr S.P., and Greenberg M.S. Naloxone-reversible analgesic response to combat-related stimuli in posttraumatic stress disorder. A pilot study. Arch. Gen. Psychiatry 47 (1990) 541-544
56. Ratliff N.B., and Kerski D. Depersonalization treated with fluoxetine. Am. J. Psychiatry 152 (1995) 1689-1690
57. Ross C.A., Joshi S., and Currie R. Dissociative experiences in the general population: a factor analysis. Hosp. Community Psychiatry 42 (1991) 297-301
58. Roth M. The phobic anxiety-depersonalization syndrome and some general aetiological problems in psychiatry. J. Neuropsychiatry 1 (1960) 293-306
59. Roth M., and Argyle N. Anxiety, panic and phobic disorders: an overview. J. Psychiatr. Res. 22 Suppl 1 (1988) 33-54
60. Sachdev P. Citalopram-Clonazepam combination for primary depersonalization disorder: a case report. Aust. N. Z. J. Psychiatry 36 (2002) 424-425
61. Schilder P. The social neurosis. Psychoanal. Rev. 25 (1938) 1-19
62. Sedman G., and Kenna J.C. Depersonalization and mood changes in schizophrenia. Br. J. Psychiatry 109 (1963) 669-673
63. Sedman G., and Reed G.F. Depersonalization phenomena in obsessional personalities and in depression. Br. J. Psychiatry 109 (1963) 376-379
64. Segui J., Marquez M., Garcia L., Canet J., Salvador-Carulla L., and Ortiz M. Depersonalization in panic disorder: a clinical study. Compr. Psychiatry 41 (2000) 172-178
65. Shelton R.C., and Loosen P.T. Sleep deprivation accelerates the response to nortriptyline. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 17 (1993) 113-123
66. Shin L.M., Kosslyn S.M., McNally R.J., Alpert N.M., Thompson W.L., Rauch S.L., Macklin M.L., and Pitman R.K. Visual imagery and perception in posttraumatic stress disorder. A positron emission tomographic investigation. Arch. Gen. Psychiatry 54 3 (1997) 233-241
67. Sierra M., and Berrios G.E. Depersonalization: neurobiological perspectives. Biol. Psychiatry 44 (1998) 898-908
68. Sierra M., and Berrios G.E. The phenomenological stability of depersonalization: comparing the old with the new. J. Nerv. Ment. Dis. 189 (2001) 629-636
69. Sierra M., Senior C., Dalton J., McDonough M., Bond A., Phillips M.L., O'Dwyer A.M., and David A.S. Autonomic response in depersonalization disorder. Arch. Gen. Psychiatry 59 (2002) 833-838
70. Sierra M., Lopera F., Lambert M.V., Phillips M.L., and David A.S. Separating depersonalisation and derealisation: the relevance of the "lesion method". J. Neurol. Neurosurg. Psychiatry 72 (2002) 530-532
71. Sierra M., Phillips M.L., Ivin G., Krystal J., and David A.S. A placebo-controlled, cross-over trial of lamotrigine in depersonalization disorder. J. Psychopharmacol. 17 (2003) 103-105
72. Simeon D. Depersonalisation disorder: a contemporary overview. CNS Drugs 18 (2004) 343-354
73. Simeon D., and Knutelska M. An open trial of naltrexone in the treatment of depersonalization disorder. J. Clin. Psychopharmacol. 25 (2005) 267-270
74. Simeon D., Stein D.J., and Hollander E. Treatment of depersonalization disorder with clomipramine. Biol. Psychiatry 44 (1998) 302-303
75. Simeon D., Guralnik O., Hazlett E.A., Spiegel-Cohen J., Hollander E., and Buchsbaum M.S. Feeling unreal: a PET study of depersonalization disorder. Am. J. Psychiatry 157 (2000) 1782-1788
76. Simeon D., Guralnik O., Knutelska M., Hollander E., and Schmeidler J. Hypothalamic-pituitary-adrenal axis dysregulation in depersonalization disorder. Neuropsychopharmacology 25 (2001) 793-795
77. Simeon D., Guralnik O., Knutelska M., Yehuda R., and Schmeidler J. Basal norepinephrine in depersonalization disorder. Psychiatry Res. 121 (2003) 93-97
78. Simeon D., Knutelska M., Nelson D., and Guralnik O. Feeling unreal: a depersonalization disorder update of 117 cases. J. Clin. Psychiatry 64 (2003) 990-997
79. Simeon D., Guralnik O., Schmeidler J., and Knutelska M. Fluoxetine therapy in depersonalisation disorder: randomised controlled trial. Br. J. Psychiatry 185 (2004) 31-36
80. Sokolski K.N., and Denson T.F. Exacerbation of mania secondary to right temporal lobe astrocytoma in a bipolar patient previously stabilized on valproate. Cogn. Behav. Neurol. 16 (2003) 234-238
81. Stanton B.R., David A.S., Cleare A.J., Sierra M., Lambert M.V., Phillips M.L., Porter R.J., Gallagher P., and Young A.H. Basal activity of the hypothalamic-pituitary-adrenal axis in patients with depersonalization disorder. Psychiatry Res. 104 (2001) 85-89
82. Stein M.B., Goldin P.R., Sarren J., Zorilla L.T.E., and Brown G.G. Increased amygdala activation to angry and contemptuous faces in generalized social phobia. Arch. Gen. Psychiatry 59 (2002) 1027-1034
83. Strickland P.L., Deakin J.F., Percival C., Dixon J., Gater R.A., and Goldberg D.P. Bio-social origins of depression in the community. Interactions between social adversity, cortisol and serotonin neurotransmission. Br. J. Psychiatry 180 (2002) 168-173
84. Strohle A., Kumpfel T., and Sonntag A. Paroxetine for depersonalization associated with multiple sclerosis. Am. J. Psychiatry 157 (2000) 150
85. Vovin R., Eryshev O.F., and Khvilivitskii T. Clinical features of manic-depressive psychosis with organic brain defects. Zh Nevropatol Psikhiatr Im S S Korsakova 78 (1978) 397-402
86. Walsh S.L., Strain E.C., Abreu M.E., and Bigelow G.E. Enadoline, a selective kappa opioid agonist: comparison with butorphanol and hydromorphone in humans. Psychopharmacology (Berl.) 157 (2001) 151-162
87. Watts C.A. A long-term follow-up of schizophrenic patients: 1946-1983. J. Clin. Psychiatry 46 (1985) 210-216
88. Wilkinson D.J., Thompson J.M., Lambert G.W., Jennings G.L., Schwarz R.G., Jefferys D., Turner A.G., and Esler M.D. Sympathetic activity in patients with panic disorder at rest, under laboratory mental stress, and during panic attacks. Arch. Gen. Psychiatry 55 (1998) 511-520
89. Ziemann U. TMS induced plasticity in human cortex. Rev. Neurosci. 15 (2004) 253-266